Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT02581059
Title	Efficacy of Ginseng for Patients on Regorafenib
Recruitment	Terminated
Gender	both
Phase	Phase II
Variant Requirements	No
Sponsors	Hoosier Cancer Research Network
Indications	colon adenocarcinoma
Therapies	Regorafenib
Age Groups:	adult
Covered Countries	USA

Filter rows:

Showing 1 to 5 of 5 entries

Facility	City	State	Zip	Country	Details
Altantic Health System	Morristown	New Jersey	07960	United States	Details
Comprehensive Cancer Center at Wake Forest Baptist	Winston-Salem	North Carolina	27157	United States	Details
Gettysburg Cancer Center	Gettysburg	Pennsylvania	17325	United States	Details
Indiana Univeristy Melvin and Bren Simon Cancer Center	Indianapolis	Indiana	46202	United States	Details
IU Health Central Indiana Cancer Centers	Indianapolis	Indiana	46219	United States	Details

Showing 1 to 5 of 5 entries

Filter rows:

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field